Patient-Focused Approach: The team believes in open communication and collaboration, ensuring that we understand the treatment plan and feel good about every step
Poling LL, Cocozziello D, He M, Hurh E, Lobbardi R, Jackson KL, et al
Approves a New Pill to Slash Cholesterol Levels The New York Times * FDA Approves First-of-Its-Kind Cholesterol Pill, Ushering In New Wave of Treatment WSJ * Drugmaker Merck announces approval of new cholesterol-fighting drug The Guardian * Merck scores at FDA as Lipfendra becomes world's first oral PCSK9 treatment Fierce Pharma #Merck #Cholesterol #FDAApproval #Lipfendra #HealthInnovation To view or add a comment, sign in FDA has approved the first-ever oral PCSK9 drug for milliions battling high cholesterol
doi: 10.1210/jc.2005-0331 150 Lindberg-LarsenRMllerNSchmitzONielsenSAndersenMOrskovHet al
Our sessions are conducted in a clinical environment, supervised by a physician because we do prioritize our patients safety
10.3390/ijms242316736 134 ZhangS